E.V. Tax Credits Are a Plus, but Flaws Remain, Study Finds
Posted inAutomobiles Biden, Joseph R Jr Carbon Dioxide Electric and Hybrid Vehicles Energy Efficiency Environment Fuel Emissions (Transportation) Global Warming Inflation Reduction Act of 2022 Law and Legislation National Bureau of Economic Research Tax Credits, Deductions and Exemptions United States

E.V. Tax Credits Are a Plus, but Flaws Remain, Study Finds

The Inflation Reduction Act was a compromise between competing priorities. Evaluating the law on the effectiveness of the $7,500 tax credit for E.V.s is tricky.
For Companies in China, Pulling Out of Xinjiang Poses ‘Messy Dilemma’
Posted inBASF SE Boycotts China Embargoes and Sanctions European Union Chamber of Commerce in China Fashion and Apparel Forced Labor H & M Hennes & Mauritz AB Human Rights and Human Rights Violations International Trade and World Market PVH Corp United States Volkswagen AG

For Companies in China, Pulling Out of Xinjiang Poses ‘Messy Dilemma’

Beijing’s investigation of the parent of Calvin Klein and Tommy Hilfiger, which stopped buying goods from Xinjiang, has put global firms in a difficult position.
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
Posted inAlzheimer's Disease Cassava Sciences Inc City University of New York Clinical Trials Dementia Drugs (Pharmaceuticals) Falsification of Data Food and Drug Administration Regulation and Deregulation of Industry Securities and Commodities Violations Securities and Exchange Commission United States Wang, Hoau-Yan

Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.